Yao, L., Zhu, X., Shao, B., Liu, R., Li, Z., Wu, L., . . . Cao, Q. (2021). Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Yao, Lingya, Xiao Zhu, Bule Shao, Rongbei Liu, Zhilun Li, Lexi Wu, Jin Chen, y Qian Cao. Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Yao, Lingya, et al. Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study. Frontiers Media S.A, 2021.
Precaución: Estas citas no son 100% exactas.